logo-loader
viewTekcapital PLC

Tekcapital portfolio company working on innovation that could be used to treat coronavirus sufferers

Belluscura and its research partner Separation Design Group have filed a patent on an oxygen enrichment system for people suffering acute respiratory distress, which occurs in those worst affected by the illness

Tekcapital PLC -
The outbreak has brought paralysis to parts of China including Wuhan, the centre of the epidemic

Intellectual property specialist Tekcapital PLC (LON:TEK) said one of its portfolio companies is working on a technology that could be used to treat coronavirus victims.

Belluscura and its research partner Separation Design Group have filed a patent on an oxygen enrichment system for people suffering acute respiratory distress, which occurs in those worst affected by the illness.

The two have developed an integrated portable extracorporeal oxygenation and carbon dioxide removal system. The unit is essentially a next-generation ECMO machine, which pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest.

Belluscura, in which Tekcapital has an 18.9% stake, is focused on developing oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applied to a single product or product line.

It is launching its first product, the X-PLOR portable oxygen concentrator, this year into the respiratory treatment field. It will be used to treat people with chronic obstructive pulmonary disease.

The shares were changing hands for 5.3p each mid-afternoon, up 9.3%.

Quick facts: Tekcapital PLC

Price: 12.25 GBX

LSE:TEK
Market: LSE
Market Cap: £10.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: MedMen up 11% despite co-founders departure, Green Growth...

The North American Marijuana Index was trending up today to reach 93 points. Medmen Enterprises (OTCMKTS:MMNFF) was up more than 11% today. No new news to report today on the Los Angeles based cannabis company. Earlier This month, its co-founders Adam Bierman and Andrew Modlin left the board...

12 hours, 1 minute ago

2 min read